By Swati Pandey SYDNEY (Reuters) – Australia on Friday reported its first fatality from blood clots in a recipient of AstraZeneca’s COVID-19 shot, and its regulator said there was a likely link between the 48-year-old woman’s death and the vaccine. Hers was the third instance of the rare blood clots appearing in people who have been administered the vaccine in Australia. […] It said it was “carefully reviewing” similar instances in Australia. […] There had been at least 885,000 doses of the AstraZeneca vaccines administered in Australia so far, equating to a frequency of instance of blood clot in every 295,000 cases, the TGA said. […] The UK regulator, the Medicines and Healthcare Products Regulatory Agency, has concluded from its review of cases reported in the UK that the overall risk of cerebral venous sinus thrombosis – a rare blood clot in the brain – was approximately 1 in 250,000 who receive the vaccine.
Click here to read the full article